- Home
- TIRX vs HLVX Comparison
TIRX vs HLVX Comparison
Compare TIRX & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIRX
- HLVX
- Stock Information
- Founded
- TIRX 2010
- HLVX 2020
- Country
- TIRX China
- HLVX United States
- Employees
- TIRX N/A
- HLVX N/A
- Industry
- TIRX Specialty Insurers
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- TIRX Finance
- HLVX Health Care
- Exchange
- TIRX Nasdaq
- HLVX Nasdaq
- Market Cap
- TIRX 118.4M
- HLVX 104.3M
- IPO Year
- TIRX 2021
- HLVX 2022
- Fundamental
- Price
- TIRX $0.61
- HLVX $2.09
- Analyst Decision
- TIRX
- HLVX Hold
- Analyst Count
- TIRX 0
- HLVX 1
- Target Price
- TIRX N/A
- HLVX $2.00
- AVG Volume (30 Days)
- TIRX 66.6K
- HLVX 1.0M
- Earning Date
- TIRX 09-09-2025
- HLVX 08-06-2025
- Dividend Yield
- TIRX N/A
- HLVX N/A
- EPS Growth
- TIRX N/A
- HLVX N/A
- EPS
- TIRX N/A
- HLVX N/A
- Revenue
- TIRX N/A
- HLVX N/A
- Revenue This Year
- TIRX N/A
- HLVX N/A
- Revenue Next Year
- TIRX N/A
- HLVX N/A
- P/E Ratio
- TIRX N/A
- HLVX N/A
- Revenue Growth
- TIRX 158.74
- HLVX N/A
- 52 Week Low
- TIRX $0.59
- HLVX $1.34
- 52 Week High
- TIRX $2.65
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- TIRX 18.36
- HLVX 51.70
- Support Level
- TIRX $0.59
- HLVX $2.05
- Resistance Level
- TIRX $0.90
- HLVX $2.13
- Average True Range (ATR)
- TIRX 0.08
- HLVX 0.03
- MACD
- TIRX -0.01
- HLVX 0.00
- Stochastic Oscillator
- TIRX 1.79
- HLVX 37.50
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.